Insulin expressing hepatocytes not destroyed in transgenic NOD mice
- 期刊名称Journal of Autoimmune Diseases
- 作者Tabiin, Muhammad T; White, Christopher P; Morahan, Grant; Tuch, Bernard E
- 卷第1卷
- 期第1期
- 印刷ISSN1740-2557
- 文件大小2597.50KB
- 发表时间2004-12
- DOI10.1186/1740-2557-1-3
What are the Considerations in Balancing Benefits and Risks in Iron Treatment?Fishbane, Steven; Fishbane, Steven · Seminars in Dialysis · 2016
How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients?Shah, Hitesh H.; Fishbane, Steven N.; Fishbane, Steven N. · Seminars in Dialysis · 2013
How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients?Shirazian, Shayan; Grant, Candace; Miller, Ilene; Fishbane, Steven; Fishbane, Steven N. · Seminars in Dialysis · 2013
Safety of Intravenous Iron During InfectionsSteven Fishbane · 2001
Hepatic iron in hemodialysis patientsFISHBANE, STEVEN; MIYAWAKI, NOBUYUKI; MASANI, NAVEED · Kidney International · 2004
Rechallenging Patients Allergic to Iron DextranSteven Fishbane · 1998
Pharmacokinetics and utilization of iron sucroseSteven Fishbane · 2003
Safety issues with iron sucroseSteven Fishbane · 2003